Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).

Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, .... (2022). Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. https://doi.org/10.1186/s40779-022-00406-y

@article{paper35978389, title={ Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). }, author={ Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, Fan ZL, Han P, Huang YR, Huang X, Li M, Li XD, Li YN, Li XH, Liang CZ, Liu JM, Ma HS, Qi J, Shi JQ, Wang J, Wang DL, Wang ZP, Wang YY, Wang YB, Wei Q, Xia HB, Xing JC, Yan SY, Zhang XP, Zheng GY, Xing NZ, He DL, Wang XH, Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange, Promotive Association for Medical, Health Care (CPAM-UHPA). }, journal={ Mil Med Res }, year={ 2022 }, doi={ 10.1186/s40779-022-00406-y }, pmid={ 35978389 } }